Deprecated: The each() function is deprecated. This message will be suppressed on further calls in /home/zhenxiangba/zhenxiangba.com/public_html/phproxy-improved-master/index.php on line 456
JP7576541B2 - Method for producing oil-in-water cream - Google Patents
[go: Go Back, main page]

JP7576541B2 - Method for producing oil-in-water cream - Google Patents

Method for producing oil-in-water cream Download PDF

Info

Publication number
JP7576541B2
JP7576541B2 JP2021527789A JP2021527789A JP7576541B2 JP 7576541 B2 JP7576541 B2 JP 7576541B2 JP 2021527789 A JP2021527789 A JP 2021527789A JP 2021527789 A JP2021527789 A JP 2021527789A JP 7576541 B2 JP7576541 B2 JP 7576541B2
Authority
JP
Japan
Prior art keywords
oil
active ingredient
aqueous phase
oil phase
water
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Active
Application number
JP2021527789A
Other languages
Japanese (ja)
Other versions
JPWO2020262641A1 (en
Inventor
健 川崎
和樹 伊藤
貴弘 大久保
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Lion Corp
Original Assignee
Lion Corp
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Lion Corp filed Critical Lion Corp
Publication of JPWO2020262641A1 publication Critical patent/JPWO2020262641A1/ja
Application granted granted Critical
Publication of JP7576541B2 publication Critical patent/JP7576541B2/en
Active legal-status Critical Current
Anticipated expiration legal-status Critical

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/10Dispersions; Emulsions
    • A61K9/107Emulsions ; Emulsion preconcentrates; Micelles
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/13Amines
    • A61K31/135Amines having aromatic rings, e.g. ketamine, nortriptyline
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K45/00Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/16Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing nitrogen, e.g. nitro-, nitroso-, azo-compounds, nitriles, cyanates
    • A61K47/18Amines; Amides; Ureas; Quaternary ammonium compounds; Amino acids; Oligopeptides having up to five amino acids
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/26Carbohydrates, e.g. sugar alcohols, amino sugars, nucleic acids, mono-, di- or oligo-saccharides; Derivatives thereof, e.g. polysorbates, sorbitan fatty acid esters or glycyrrhizin
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/30Macromolecular organic or inorganic compounds, e.g. inorganic polyphosphates
    • A61K47/32Macromolecular compounds obtained by reactions only involving carbon-to-carbon unsaturated bonds, e.g. carbomers, poly(meth)acrylates, or polyvinyl pyrrolidone
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00Cosmetics or similar toiletry preparations
    • A61K8/02Cosmetics or similar toiletry preparations characterised by special physical form
    • A61K8/04Dispersions; Emulsions
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00Cosmetics or similar toiletry preparations
    • A61K8/02Cosmetics or similar toiletry preparations characterised by special physical form
    • A61K8/04Dispersions; Emulsions
    • A61K8/06Emulsions
    • A61K8/062Oil-in-water emulsions
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00Cosmetics or similar toiletry preparations
    • A61K8/18Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/30Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
    • A61K8/31Hydrocarbons
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00Cosmetics or similar toiletry preparations
    • A61K8/18Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/30Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
    • A61K8/40Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing nitrogen
    • A61K8/41Amines
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00Cosmetics or similar toiletry preparations
    • A61K8/18Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/72Cosmetics or similar toiletry preparations characterised by the composition containing organic macromolecular compounds
    • A61K8/81Cosmetics or similar toiletry preparations characterised by the composition containing organic macromolecular compounds obtained by reactions involving only carbon-to-carbon unsaturated bonds
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00Cosmetics or similar toiletry preparations
    • A61K8/18Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/72Cosmetics or similar toiletry preparations characterised by the composition containing organic macromolecular compounds
    • A61K8/81Cosmetics or similar toiletry preparations characterised by the composition containing organic macromolecular compounds obtained by reactions involving only carbon-to-carbon unsaturated bonds
    • A61K8/8141Compositions of homopolymers or copolymers of compounds having one or more unsaturated aliphatic radicals, each having only one carbon-to-carbon double bond, and at least one being terminated by only one carboxyl radical, or of salts, anhydrides, esters, amides, imides or nitriles thereof; Compositions of derivatives of such polymers
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/06Ointments; Bases therefor; Other semi-solid forms, e.g. creams, sticks, gels
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/10Dispersions; Emulsions
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00Drugs for dermatological disorders
    • A61P17/04Antipruritics
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04Antibacterial agents
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00Drugs for immunological or allergic disorders
    • A61P37/08Antiallergic agents
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61QSPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
    • A61Q19/00Preparations for care of the skin
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K2800/00Properties of cosmetic compositions or active ingredients thereof or formulation aids used therein and process related aspects
    • A61K2800/10General cosmetic use
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K2800/00Properties of cosmetic compositions or active ingredients thereof or formulation aids used therein and process related aspects
    • A61K2800/40Chemical, physico-chemical or functional or structural properties of particular ingredients
    • A61K2800/48Thickener, Thickening system

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Epidemiology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Medicinal Chemistry (AREA)
  • Birds (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Oil, Petroleum & Natural Gas (AREA)
  • Engineering & Computer Science (AREA)
  • Dispersion Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Dermatology (AREA)
  • Inorganic Chemistry (AREA)
  • Biochemistry (AREA)
  • Molecular Biology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Pulmonology (AREA)
  • Immunology (AREA)
  • Communicable Diseases (AREA)
  • Oncology (AREA)
  • Pain & Pain Management (AREA)
  • Rheumatology (AREA)
  • Medicinal Preparation (AREA)
  • Cosmetics (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Steroid Compounds (AREA)

Description

本発明は、粘度が均一な水中油型クリーム剤を効率的に製造する方法に関する。 The present invention relates to a method for efficiently producing oil-in-water creams with uniform viscosity.

カルボキシビニルポリマーは、塩基性物質(アルカリ剤)により中和されて増粘性を示すことが知られている。この性質を利用して、カルボキシビニルポリマーは医薬品や化粧品等の増粘剤として使用されている(特許文献1)。Carboxyvinyl polymers are known to thicken when neutralized with a basic substance (alkaline agent). Taking advantage of this property, carboxyvinyl polymers are used as thickeners for pharmaceuticals, cosmetics, etc. (Patent Document 1).

特開2013-256472号公報JP 2013-256472 A

増粘剤としてカルボキシビニルポリマーを配合してなる水中油型クリーム剤では、粘度の均一性が商品価値上求められる。
水中油型クリーム剤の製造方法では、カルボキシビニルポリマーを中和する工程と、水相に油相を乳化させる工程が必要になるところ、従来技術では、乳化工程終了後に中和工程を実施していた(特許文献1の実施例4)。
しかし、乳化工程終了後に中和工程を行うと粘度が均一な水中油型クリーム剤の生成に時間を要することを本発明者は見いだした。
In oil-in-water creams containing carboxyvinyl polymer as a thickener, uniformity of viscosity is required for commercial value.
The method for producing an oil-in-water cream requires a step of neutralizing a carboxyvinyl polymer and a step of emulsifying an oil phase in an aqueous phase, but in the prior art, the neutralization step was carried out after the emulsification step (Example 4 of Patent Document 1).
However, the present inventors have found that if a neutralization step is carried out after the emulsification step, it takes a long time to produce an oil-in-water cream having a uniform viscosity.

水中油型クリーム剤の生産性向上について鋭意検討した結果、本発明者は、アルカリ剤を予め配合した油相を水相に添加すると、乳化とカルボキシビニルポリマーの中和とが同時に起こり、粘度が均一な水中油型クリーム剤の生成に要する時間を短縮できることを見いだした。本発明は、この知見に基づいてなされたものである。As a result of extensive research into improving the productivity of oil-in-water creams, the inventors discovered that adding an oil phase containing an alkaline agent to an aqueous phase simultaneously causes emulsification and neutralization of the carboxyvinyl polymer, thereby shortening the time required to produce an oil-in-water cream with a uniform viscosity. The present invention is based on this finding.

すなわち、本発明は、以下の〔1〕~〔6〕に関するものである。
〔1〕カルボキシビニルポリマーを含む水相へ、アルカリ剤、有効成分及び乳化剤を含む油相を添加して乳化を行う工程を含むことを特徴とする、水中油型クリーム剤の製造方法。
〔2〕有効成分が、抗ヒスタミン剤、鎮痒剤、消炎鎮痛剤及び殺菌剤からなる群より選ばれる1種以上の物質である、前記〔1〕に記載の製造方法。
〔3〕アルカリ剤、有効成分及び乳化剤を含む油相(第1の油相)を添加する前に、第2の有効成分を含む第2の油相を水相へ添加する工程を更に含む、前記〔1〕又は〔2〕に記載の製造方法。
〔4〕第2の有効成分が25℃で液体の物質であり、かつ、第1の油相に含まれる有効成分が25℃で固体の物質である、前記〔3〕に記載の製造方法。
〔5〕第2の有効成分が、抗ヒスタミン剤、鎮痒剤、消炎鎮痛剤及び殺菌剤からなる群より選ばれる1種以上の物質である、前記〔3〕又は〔4〕に記載の製造方法。
〔6〕アルカリ剤がアミン類である、前記〔1〕~〔5〕のいずれか1項に記載の製造方法。
That is, the present invention relates to the following [1] to [6].
[1] A method for producing an oil-in-water cream, comprising the step of adding an oil phase containing an alkaline agent, an active ingredient, and an emulsifier to an aqueous phase containing a carboxyvinyl polymer to emulsify the oil phase.
[2] The method for producing the composition according to [1] above, wherein the active ingredient is one or more substances selected from the group consisting of antihistamines, antipruritics, anti-inflammatory analgesics and disinfectants.
[3] The manufacturing method described in [1] or [2] above, further comprising a step of adding a second oil phase containing a second active ingredient to the aqueous phase before adding the oil phase (first oil phase) containing an alkaline agent, an active ingredient and an emulsifier.
[4] The manufacturing method described in [3] above, wherein the second active ingredient is a liquid substance at 25°C and the active ingredient contained in the first oil phase is a solid substance at 25°C.
[5] The manufacturing method according to [3] or [4] above, wherein the second active ingredient is one or more substances selected from the group consisting of antihistamines, antipruritics, anti-inflammatory analgesics and disinfectants.
[6] The method according to any one of [1] to [5] above, wherein the alkaline agent is an amine.

後述の実施例で示されるように、本発明の製造方法に従うと、粘度が均一な水中油型クリーム剤の生成に要する時間を短縮して、水中油型クリーム剤の生産性を向上できる。As shown in the examples below, the manufacturing method of the present invention can shorten the time required to produce an oil-in-water cream with a uniform viscosity, thereby improving the productivity of oil-in-water cream.

本発明の水中油型クリーム剤の製造方法は、カルボキシビニルポリマーを含む水相へ、アルカリ剤、有効成分及び乳化剤を含む油相を添加して乳化を行う工程を含むことを特徴とする。The method for producing an oil-in-water cream of the present invention is characterized by including a step of emulsifying the oil by adding an oil phase containing an alkaline agent, an active ingredient and an emulsifier to an aqueous phase containing a carboxyvinyl polymer.

〔水相〕
水相は、カルボキシビニルポリマーを必須成分として含む。カルボキシビニルポリマーは、アルカリ剤により中和されることで増粘する性質により、増粘剤として配合する。
カルボキシビニルポリマーとしては、水中油型クリーム剤に配合可能なものを特に制限無く使用できるが、例えば、医薬品添加物規格2018(厚生労働省)の「カルボキシビニルポリマー」欄に記載された規格を満たすものが好ましい。
カルボキシビニルポリマーの配合量は、意図する水中油型クリーム剤の粘度に応じて適宜設定できるが、例えば、水中油型クリーム剤の総質量に対して0.1~3.0質量%、好ましくは0.5~1.5質量%である。また、水相の総質量に対しては、例えば0.3~3.0質量%、好ましくは0.5~2.0質量%である。水相を調製する際の後述のプレミックスの総質量に対しては、例えば0.5~5.0質量%、好ましくは1.0~3.0質量%である。
[Aqueous Phase]
The aqueous phase contains a carboxyvinyl polymer as an essential component. The carboxyvinyl polymer is blended as a thickening agent because it thickens when neutralized with an alkaline agent.
Any carboxyvinyl polymer that can be incorporated into an oil-in-water cream can be used without particular limitation as the carboxyvinyl polymer. For example, a polymer that satisfies the standards set forth in the "Carboxyvinyl Polymer" column of the Pharmaceutical Excipients Standards 2018 (Ministry of Health, Labour and Welfare) is preferred.
The amount of the carboxyvinyl polymer can be appropriately set depending on the intended viscosity of the oil-in-water cream, but is, for example, 0.1 to 3.0% by mass, preferably 0.5 to 1.5% by mass, based on the total mass of the oil-in-water cream. The amount is, for example, 0.3 to 3.0% by mass, preferably 0.5 to 2.0% by mass, based on the total mass of the aqueous phase. The amount is, for example, 0.5 to 5.0% by mass, preferably 1.0 to 3.0% by mass, based on the total mass of the premix described below when preparing the aqueous phase.

カルボキシビニルポリマーを水中に分散させるために、水相に界面活性剤を配合してもよい。界面活性剤としては、カルボキシビニルポリマーを分散できるものを特に制限無く使用できるが、非イオン性界面活性剤が好ましい。具体例としては、ソルビタンモノイソステアレート、ソルビタンモノラウレート、ソルビタンモノパルミテート、ソルビタンモノステアレート等のソルビタン脂肪酸エステル類;モノステアリン酸プロピレングリコール等のプロピレングリコール脂肪酸エステル類;ポリオキシエチレン硬化ヒマシ油;モノラウリル酸ポリオキシエチレン(20)ソルビタン(ポリソルベート20)、モノステアリン酸ポリオキシエチレン(20)ソルビタン(ポリソルベート60)、モノオレイン酸ポリオキシエチレン(20)ソルビタン(ポリソルベート80)等のポリオキシエチレンソルビタン脂肪酸エステル類;ポリオキシアルキレンアルキルエーテル等が挙げられ、好ましくはポリオキシエチレンソルビタン脂肪酸エステル類である。
水相にカルボキシビニルポリマーを分散させる際の界面活性剤の配合量は、カルボキシビニルポリマーの配合量や使用する界面活性剤の種類に応じて適宜設定できるが、例えば、水相の総質量に対して0.02~0.2質量%、好ましくは0.05~0.2質量%である。また、水相を調製する際の後述のプレミックスの総質量に対しては、例えば0.05~0.5質量%、好ましくは0.1~0.3質量%である。
In order to disperse the carboxyvinyl polymer in water, a surfactant may be added to the aqueous phase. The surfactant may be any surfactant capable of dispersing the carboxyvinyl polymer, but is preferably a nonionic surfactant. Specific examples include sorbitan fatty acid esters such as sorbitan monoisostearate, sorbitan monolaurate, sorbitan monopalmitate, and sorbitan monostearate; propylene glycol fatty acid esters such as propylene glycol monostearate; polyoxyethylene hydrogenated castor oil; polyoxyethylene sorbitan fatty acid esters such as polyoxyethylene (20) sorbitan monolaurate (polysorbate 20), polyoxyethylene (20) sorbitan monostearate (polysorbate 60), and polyoxyethylene (20) sorbitan monooleate (polysorbate 80); polyoxyalkylene alkyl ethers, and the like, and preferably polyoxyethylene sorbitan fatty acid esters.
The amount of surfactant used when dispersing the carboxyvinyl polymer in the aqueous phase can be appropriately set depending on the amount of the carboxyvinyl polymer and the type of surfactant used, but is, for example, 0.02 to 0.2% by mass, preferably 0.05 to 0.2% by mass, based on the total mass of the aqueous phase. Also, the amount is, for example, 0.05 to 0.5% by mass, preferably 0.1 to 0.3% by mass, based on the total mass of the premix described below when preparing the aqueous phase.

水相を構成する水としては、水中油型クリーム剤へ配合可能なものを特に制限無く使用できる。具体例としては、精製水、純水、蒸留水やイオン交換水等が挙げられ、精製水が好ましい。
水の配合量は特に制限されず、所望の成分組成や粘度を達成するために適量を配合できる。
The water constituting the aqueous phase can be any water that can be incorporated into an oil-in-water cream without any particular limitations. Specific examples include purified water, pure water, distilled water, ion-exchanged water, etc., and purified water is preferred.
The amount of water to be added is not particularly limited, and an appropriate amount can be added to achieve the desired component composition and viscosity.

水相は、前記の必須成分の他、キレート剤等の任意成分の1種以上を含んでいてもよい。
キレート剤としては、エデト酸ナトリウム等が挙げられる。
In addition to the essential components described above, the aqueous phase may contain one or more optional components such as a chelating agent.
Chelating agents include sodium edetate and the like.

水相の各構成成分は公知物質であり、市場で容易に入手可能であるか、又は、公知の方法で調製可能である。 Each component of the aqueous phase is a known substance and is readily available on the market or can be prepared by known methods.

〔水相の調製方法〕
水相の調製方法は、カルボキシビニルポリマーの均一な分散状態を得られる限り特に制限されないが、下記工程(1)~(2)を含む方法が好ましい。
[Preparation of aqueous phase]
The method for preparing the aqueous phase is not particularly limited as long as it can provide a uniformly dispersed state of the carboxyvinyl polymer, but a method including the following steps (1) and (2) is preferred.

工程(1):プレミックスの調製
攪拌機を備えた予備配合槽内に水(好ましくは常温の精製水)を張り、攪拌を開始する。攪拌している水へ、界面活性剤、キレート剤(任意)、カルボキシビニルポリマーの順で投入し、カルボキシビニルポリマーが分散するまで攪拌を続けてプレミックスを得る。
カルボキシビニルポリマーは、水中でダマにならないよう、分割して投入することが好ましい。
カルボキシビニルポリマーが水相中で分散したことは目視でダマの発生が見られないことにより確認できる。例えば、公称目開き1.18mmの篩に分散液を一部通過させて、篩上にダマや溶け残りがないことを目視で確認する。
Step (1): Preparation of premix Pour water (preferably purified water at room temperature) into a preliminary blending tank equipped with a stirrer and start stirring. Add a surfactant, a chelating agent (optional), and a carboxyvinyl polymer in this order to the stirred water, and continue stirring until the carboxyvinyl polymer is dispersed to obtain a premix.
The carboxyvinyl polymer is preferably added in portions to prevent the polymer from forming lumps in the water.
The dispersion of the carboxyvinyl polymer in the aqueous phase can be confirmed by visually checking whether or not any lumps are formed. For example, a part of the dispersion is passed through a sieve having a nominal mesh size of 1.18 mm, and visually checked whether or not any lumps or undissolved residues are present on the sieve.

工程(2):水相の調製
(2-1):スチームジャケット、攪拌機及びホモ(又はウルトラ)ミキサーを備えた配合槽へ水(好ましくは精製水)を投入し、攪拌しながら加熱(好ましくは70~95℃)する。
スチームジャケットは、スチーム投入により配合槽内を加熱(殺菌)するために用いる。攪拌機は、配合槽の側面及び底面に付着した原料をかき取ることができる攪拌翼(掻取ミキサー)を備えたものが好ましく使用できる。ホモ(又はウルトラ)ミキサーは、水相へ添加された油相成分の液滴を微粒化するために用いる。
Step (2): Preparation of Water Phase (2-1): Water (preferably purified water) is charged into a blending vessel equipped with a steam jacket, a stirrer, and a homo (or ultra) mixer, and heated (preferably to 70 to 95° C.) with stirring.
The steam jacket is used to heat (sterilize) the inside of the blending tank by injecting steam. The agitator is preferably equipped with an agitating blade (scraping mixer) that can scrape off the raw materials adhering to the side and bottom of the blending tank. The homo (or ultra) mixer is used to atomize the droplets of the oil phase components added to the aqueous phase.

(2-2):加熱した水へ、工程(1)のプレミックス(好ましくは26~30℃に調節)及び洗い水(プレミックスを調製した槽の洗浄水。好ましくは精製水。好ましくは10~30℃に調節)の順で投入し、攪拌して水相を得る。
工程(2-2)は、スチームジャケットへのスチーム投入停止後(すなわち、積極的な加熱操作なし)に行って、カルボキシビニルポリマーのゲル状凝集物の生成を防止することが好ましい。ゲル状凝集物は、水中油型クリーム剤の粘度の均一性を妨げるので好ましくない。
水相の形成は目視により確認できる。
(2-2): The premix from step (1) (preferably adjusted to 26 to 30°C) and wash water (wash water from the tank in which the premix was prepared; preferably purified water; preferably adjusted to 10 to 30°C) are added in this order to heated water, and the mixture is stirred to obtain an aqueous phase.
It is preferable to carry out the step (2-2) after stopping the supply of steam to the steam jacket (i.e., without active heating operation) to prevent the formation of gel-like aggregates of the carboxyvinyl polymer, which is undesirable because it interferes with the uniformity of the viscosity of the oil-in-water cream.
The formation of the aqueous phase can be confirmed visually.

工程(2)を実施する配合槽は、後述の乳化工程を実施する真空乳化装置の主配合槽であることが好ましい。It is preferable that the blending tank in which step (2) is carried out is the main blending tank of a vacuum emulsification apparatus in which the emulsification step described below is carried out.

〔油相〕
油相は、アルカリ剤、有効成分及び乳化剤を必須成分として含む。アルカリ剤を含む油相を水相へ添加することで、乳化とカルボキシビニルポリマーの中和による増粘とを同時に行うことができる。
[Oil Phase]
The oil phase contains an alkaline agent, an active ingredient, and an emulsifier as essential components. By adding the oil phase containing the alkaline agent to the aqueous phase, emulsification and thickening due to neutralization of the carboxyvinyl polymer can be simultaneously performed.

アルカリ剤は、カルボキシビニルポリマーを中和して増粘させることができるものであれば特に制限されない。具体例としては、アミン類や、無機塩基等が挙げられ、なかでもアミン類が好ましい。
アミン類としては、トリエタノールアミンやジイソプロパノールアミン、トリイソプロパノールアミン等が挙げられ、これら第3級アミンが好ましく使用できる。
無機塩基としては、水酸化カリウムや水酸化ナトリウム等が挙げられ、水酸化カリウムが好ましい。
アルカリ剤の配合量は、配合目的に応じて適宜設定できるが、例えば、水中油型クリーム剤のpHを3~10、好ましくは4~8、さらに好ましくは4~6に調整するのに必要な量である。なお、pHは、水中油型クリーム剤2.0gを脱イオン水20mLに入れ、攪拌して測定試料を調製し、液温度20~30℃でpH測定器を用いて測定した値である。
The alkaline agent is not particularly limited as long as it can neutralize the carboxyvinyl polymer to thicken it. Specific examples include amines and inorganic bases, and among these, amines are preferred.
Examples of the amines include triethanolamine, diisopropanolamine, and triisopropanolamine, and these tertiary amines are preferably used.
Examples of the inorganic base include potassium hydroxide and sodium hydroxide, with potassium hydroxide being preferred.
The amount of alkaline agent to be added can be appropriately determined depending on the purpose of the addition, but is, for example, the amount necessary to adjust the pH of the oil-in-water cream to 3 to 10, preferably 4 to 8, and more preferably 4 to 6. The pH is measured by adding 2.0 g of the oil-in-water cream to 20 mL of deionized water and stirring to prepare a measurement sample, and measuring the value using a pH meter at a liquid temperature of 20 to 30° C.

有効成分は、水中油型クリーム剤の用途に応じて適宜選択できる。
例えば、有効成分としては、抗ヒスタミン剤、鎮痒剤、消炎鎮痛剤及び殺菌剤等が挙げられる。以下に具体例を列挙する。なお、物質名の後ろの括弧内の「液体」又は「固体」の表示は、25℃における状態を示す。
抗ヒスタミン剤としては、ジフェンヒドラミン(液体)、ジフェンヒドラミン塩酸塩(固体)や、クロルフェニラミンマレイン酸塩(固体)等が挙げられる。
鎮痒剤としては、クロタミトン(液体)が挙げられる。
消炎鎮痛剤としては、プレドニゾロン吉草酸エステル酢酸エステル(固体)、ウフェナマート(液体)、グリチルリチン酸二カリウム(固体)やイブプロフェンピコノール(液体)等が挙げられる。
殺菌剤としては、アラントイン(固体)、イソプロピルメチルフェノール(IPMP)(固体)や、ベンゼトニウム塩化物(固体)等が挙げられる。
これらの中でも、グリチルリチン酸二カリウム(固体)、イソプロピルメチルフェノール(IPMP)(固体)、ジフェンヒドラミン(液体)、ウフェナマート(液体)、イブプロフェンピコノール(液体)が好ましい。
有効成分は1種類を単独で用いてもよく、複数種類を組み合わせて用いてもよい。
有効成分の配合量は、水中油型クリーム剤の用途に応じて適宜設定できるが、例えば水中油型クリーム剤の総質量に対して1.0~10.0質量%、好ましくは1.5~6.0質量%である。
The active ingredient can be appropriately selected depending on the application of the oil-in-water cream.
For example, active ingredients include antihistamines, antipruritics, anti-inflammatory analgesics, and disinfectants. Specific examples are listed below. Note that the indication of "liquid" or "solid" in parentheses after the substance name indicates the state at 25°C.
Antihistamines include diphenhydramine (liquid), diphenhydramine hydrochloride (solid), and chlorpheniramine maleate (solid).
Antipruritic agents include crotamiton (liquid).
Examples of anti-inflammatory analgesics include prednisolone valerate acetate (solid), ufenamate (liquid), dipotassium glycyrrhizinate (solid), and ibuprofen piconol (liquid).
Examples of the disinfectant include allantoin (solid), isopropylmethylphenol (IPMP) (solid), and benzethonium chloride (solid).
Among these, dipotassium glycyrrhizinate (solid), isopropylmethylphenol (IPMP) (solid), diphenhydramine (liquid), ufenamate (liquid), and ibuprofen piconol (liquid) are preferable.
The active ingredient may be used alone or in combination of two or more kinds.
The amount of the active ingredient can be appropriately determined depending on the application of the oil-in-water cream, but is, for example, 1.0 to 10.0% by mass, preferably 1.5 to 6.0% by mass, based on the total mass of the oil-in-water cream.

乳化剤は、水相中に油相を乳化させるために配合する。
乳化剤は、有効成分の種類等に応じて適宜選択できるが、例えば、前述の水相に配合する界面活性剤が挙げられ、ポリオキシエチレンソルビタン脂肪酸エステル類が好ましく使用できる。
なお、乳化剤は、前記水相に配合する界面活性剤と同じであってもよく、異なっていてもよい。
乳化剤の配合量は、有効成分の種類や配合量に応じて適宜設定できるが、例えば、前記水相に配合する界面活性剤との合計の配合量は、水中油型クリーム剤の総質量に対して0.1~2.0質量%、好ましくは0.5~1.2質量%である。
The emulsifier is added to emulsify the oil phase in the aqueous phase.
The emulsifier can be appropriately selected depending on the type of active ingredient, etc., and examples thereof include the above-mentioned surfactants to be added to the aqueous phase, and polyoxyethylene sorbitan fatty acid esters are preferably used.
The emulsifier may be the same as or different from the surfactant to be blended in the aqueous phase.
The amount of the emulsifier to be added can be appropriately set depending on the type and amount of the active ingredient; for example, the total amount of the emulsifier and the surfactant to be added to the aqueous phase is 0.1 to 2.0% by mass, and preferably 0.5 to 1.2% by mass, based on the total mass of the oil-in-water cream.

油相は、前記の必須成分の他、基剤、香料、防腐剤、安定化剤、酸化防止剤や、着色剤等の任意成分の1種以上を含んでいてもよい。In addition to the essential components described above, the oil phase may contain one or more optional components such as bases, fragrances, preservatives, stabilizers, antioxidants, and colorants.

基剤は、有効成分の溶媒として配合する。有効成分が25℃で固体の物質である場合、基剤を用いることが好ましい。基剤は有効成分の種類に応じて適宜選択できるが、例えば、2-オクチルドデカノール、1,3-ブチレングリコール等が挙げられる。
基剤は1種類を単独で用いてもよく、複数種類を組み合わせて用いてもよい。
基剤の配合量は、有効成分の種類や配合量に応じて適宜設定できるが、例えば、水中油型クリーム剤の総質量に対して11.0~18.5質量%、好ましくは12.0~16.0質量%である。
The base is blended as a solvent for the active ingredient. When the active ingredient is a solid substance at 25° C., it is preferable to use a base. The base can be appropriately selected depending on the type of active ingredient, and examples thereof include 2-octyldodecanol, 1,3-butylene glycol, etc.
The base may be used alone or in combination of two or more kinds.
The amount of the base can be appropriately set depending on the type and amount of the active ingredient, but is, for example, 11.0 to 18.5% by mass, preferably 12.0 to 16.0% by mass, based on the total mass of the oil-in-water cream.

油相の各構成成分は公知物質であり、市場で容易に入手可能であるか、又は、公知の方法で調製可能である。Each component of the oil phase is a known substance and is readily available on the market or can be prepared by known methods.

〔油相の調製方法〕
油相の調製方法は、各成分が混合した状態を得られる限り特に制限されないが、例えば、撹拌装置(撹拌翼やパルセーター)を備えた配合槽へ、有効成分、香料(任意)、基剤(任意)、乳化剤、防腐剤(任意)及びアルカリ剤を投入し、各成分が溶解するまで攪拌を続けることで実施できる。なお、各成分の投入順序は前記と異なっていてもよい。
各成分の溶解を促進するため、全成分投入後の攪拌を加熱下(好ましくは80~85℃)で行うことが好ましい。
各成分の溶解は目視により確認できる。
[Preparation of oil phase]
The method for preparing the oil phase is not particularly limited as long as it can obtain a mixed state of each component, but for example, it can be carried out by putting the active ingredient, flavor (optional), base (optional), emulsifier, preservative (optional) and alkali agent into a blending tank equipped with a stirring device (stirring blade or pulsator) and continuing to stir until each component is dissolved. Note that the order of putting each component in may be different from that described above.
In order to promote dissolution of each component, it is preferable to carry out stirring under heating (preferably at 80 to 85° C.) after adding all the components.
The dissolution of each component can be confirmed visually.

配合量が異なる複数種類の有効成分を用いる場合、複数種類の油相を調製してもよい。例えば、配合量が相対的に少ない有効成分をアルカリ剤及び乳化剤を含む前記油相(以下「第1の油相」ともいう)へ配合し、配合量が相対的に多い有効成分(以下「第2の有効成分」ともいう)を別の油相(以下「第2の油相」ともいう)として配合してもよい。この場合、第1の油相を添加する前に第2の油相を水相へ添加する。第2の油相を水相に添加し攪拌下、第2の油相の油相成分が分散した水相中へ、第1の油相を添加することで、第1の油相の調製が簡略化でき、全有効成分が均一に分散した水中油型クリーム剤が得られる。
なお、第1及び第2の各油相に含まれる有効成分は1種類であってもよく、複数種類であってもよい。
When using multiple active ingredients with different amounts, multiple oil phases may be prepared. For example, an active ingredient with a relatively small amount may be blended into the oil phase (hereinafter also referred to as the "first oil phase") containing an alkaline agent and an emulsifier, and an active ingredient with a relatively large amount (hereinafter also referred to as the "second active ingredient") may be blended as another oil phase (hereinafter also referred to as the "second oil phase"). In this case, the second oil phase is added to the aqueous phase before the first oil phase is added. The second oil phase is added to the aqueous phase, and the aqueous phase in which the oil phase components of the second oil phase are dispersed is added under stirring, thereby simplifying the preparation of the first oil phase and obtaining an oil-in-water cream in which all active ingredients are uniformly dispersed.
The first and second oil phases may each contain one type of active ingredient or multiple types of active ingredients.

〔乳化工程〕
乳化工程は、水相中に油相を乳化させて水中油型クリーム剤が得られる限り特に制限されないが、例えば、攪拌している水相へ油相を添加し、乳化物が生成するまで攪拌を続けることで実施できる。
油相と水相の配合比は、水中油型クリーム剤の組成に応じて適宜設定できる。
乳化工程は、真空乳化装置で実施することが好ましい。
得られた乳化物は水中油型クリーム剤であるが、乳化物生成後、更に冷却(例えば8~30℃)下で攪拌を行ってもよい。
[Emulsification process]
The emulsification step is not particularly limited as long as an oil-in-water cream is obtained by emulsifying the oil phase in the aqueous phase. For example, the emulsification step can be carried out by adding the oil phase to the aqueous phase under stirring, and continuing to stir until an emulsion is produced.
The blending ratio of the oil phase to the aqueous phase can be appropriately set depending on the composition of the oil-in-water cream.
The emulsification step is preferably carried out in a vacuum emulsification device.
The resulting emulsion is an oil-in-water cream, and after the emulsion is produced, it may be stirred under cooling (for example, at 8 to 30° C.).

水中油型クリーム剤は、有効成分の種類に応じて医薬品(例えば、かゆみやかぶれ用医薬品、皮膚炎用医薬品など)や化粧品として使用できる。 Oil-in-water creams can be used as medicines (for example, medicines for itching and rashes, medicines for dermatitis, etc.) or cosmetics depending on the type of active ingredient.

以下、実施例により本発明を更に詳細に説明するが、本発明はこれに限定されるものではない。尚、実施例及び比較例において、各成分の配合量はすべて質量%(指定のある場合を除き、純分換算)を示す。The present invention will be described in more detail below with reference to examples, but the present invention is not limited thereto. In the examples and comparative examples, the blending amount of each component is expressed as mass% (based on the pure content unless otherwise specified).

〔実施例1〕
下記の組成を有する水中油型クリーム剤を製造した。
実施例1では、第1及び第2の油相を用いて製造を行った。

Figure 0007576541000001
Example 1
An oil-in-water cream was prepared having the following composition:
In Example 1, a preparation was carried out using a first and a second oil phase.

Figure 0007576541000001

〔水相の調製〕
下記工程(1)~(2)を含む方法により、水相を調製した。
工程(1):プレミックスの調製
攪拌機を備えた予備配合槽中で攪拌している常温の精製水40重量部へ、界面活性剤、キレート剤及びカルボキシビニルポリマーの順で投入後、カルボキシビニルポリマーが分散するまで攪拌を続けてプレミックスを得た。分散は目視により確認した。
なお、ポリソルベート60の総使用量の10%をカルボキシビニルポリマー分散用の界面活性剤としてプレミックス調製に用い、残りは乳化剤として用いた。
カルボキシビニルポリマーの配合量は、プレミックスの総質量に対して2.4質量%であった。界面活性剤の配合量は、プレミックスの総質量に対して0.24質量%であった。
[Preparation of aqueous phase]
An aqueous phase was prepared by a method including the following steps (1) and (2).
Step (1): Preparation of premix A surfactant, a chelating agent, and a carboxyvinyl polymer were added in this order to 40 parts by weight of purified water at room temperature being stirred in a preliminary blending tank equipped with a stirrer, and the stirring was continued until the carboxyvinyl polymer was dispersed to obtain a premix. The dispersion was confirmed by visual observation.
In addition, 10% of the total amount of polysorbate 60 used was used in the preparation of the premix as a surfactant for dispersing the carboxyvinyl polymer, and the remainder was used as an emulsifier.
The amount of the carboxyvinyl polymer was 2.4% by mass based on the total mass of the premix, and the amount of the surfactant was 0.24% by mass based on the total mass of the premix.

工程(2):水相の調製
(2-1):スチームジャケット、攪拌機(掻取ミキサー)及びホモミキサーを備えた真空乳化装置の主配合槽へ精製水31重量部を投入し、攪拌しながら70~95℃に加熱した。
(2-2):加熱した水へ、26~30℃の前記工程(1)で調製したプレミックス全量及び10~30℃の精製水(洗い水)12重量部の順で投入し、攪拌して水相を得た。水相の生成は目視により確認した。工程(2-2)は、スチームジャケットへのスチーム投入停止後に実施した。
カルボキシビニルポリマーの配合量は、水相の総質量に対して1.2質量%であった。界面活性剤の配合量は、水相の総質量に対して0.12質量%であった。
Step (2): Preparation of Water Phase (2-1): 31 parts by weight of purified water was charged into a main blending tank of a vacuum emulsifier equipped with a steam jacket, an agitator (scraping mixer), and a homomixer, and heated to 70 to 95° C. with stirring.
(2-2): The entire amount of the premix prepared in the above step (1) at 26 to 30°C and 12 parts by weight of purified water (washing water) at 10 to 30°C were added in this order to heated water and stirred to obtain an aqueous phase. The generation of the aqueous phase was confirmed by visual inspection. Step (2-2) was carried out after the introduction of steam into the steam jacket was stopped.
The amount of the carboxyvinyl polymer was 1.2% by mass based on the total mass of the aqueous phase, and the amount of the surfactant was 0.12% by mass based on the total mass of the aqueous phase.

〔第1の油相の調製〕
攪拌機を備えた予備配合槽へ、第1の有効成分、第1の基剤、乳化剤、防腐剤並びにアルカリ剤を投入し、各成分が溶解するまで、80~85℃下で攪拌を続けて第1の油相を調製した。各成分の溶解は目視により確認した。
〔第2の油相の調製〕
攪拌機を備えた予備配合槽へ、第2の有効成分、香料及び第2の基剤を投入し、各成分が溶解するまで攪拌を続けて第2の油相を調製した。各成分の溶解は目視により確認した。
〔乳化〕
真空乳化装置の主配合槽中で攪拌している水相へ第2の油相を添加した後、第1の油相を添加し、乳化物が生成するまで攪拌を続けた。乳化物の生成は目視により確認した。
乳化物生成後、更に冷却(8~12℃)下で攪拌を行い、水中油型クリーム剤(pH5.0。前述の測定法により測定。実施例2及び比較例も同様)を得た。
[Preparation of the first oil phase]
The first active ingredient, the first base, the emulsifier, the preservative and the alkali agent were charged into a preliminary blending tank equipped with a stirrer, and stirring was continued at 80 to 85°C until each component was dissolved, to prepare a first oil phase. The dissolution of each component was confirmed by visual inspection.
Preparation of the second oil phase
The second active ingredient, the flavor, and the second base were added to a preliminary blending tank equipped with a stirrer, and the mixture was stirred until each ingredient was dissolved to prepare a second oil phase. The dissolution of each ingredient was confirmed by visual inspection.
[Emulsification]
The second oil phase was added to the stirred aqueous phase in the main blending tank of the vacuum emulsifier, followed by the first oil phase, and stirring was continued until an emulsion was formed, which was confirmed by visual inspection.
After the emulsion was produced, the mixture was further stirred under cooling (8 to 12° C.) to obtain an oil-in-water cream (pH 5.0, measured by the above-mentioned measuring method; the same applies to Example 2 and Comparative Example).

〔実施例2〕
下記の組成を有する水中油型クリーム剤を製造した。
実施例2では、第2の油相を用いずに製造を行った。

Figure 0007576541000002
Example 2
An oil-in-water cream was prepared having the following composition:
Example 2 was prepared without a second oil phase.

Figure 0007576541000002

〔水相の調製〕
実施例1と同様の手順で水相を調製した。プレミックスの調製には精製水を38重量部使用した。
カルボキシビニルポリマーの配合量は、プレミックスの総質量に対して2.6質量%であった。界面活性剤の配合量は、プレミックスの総質量に対して0.26質量%であった。
また、カルボキシビニルポリマーの配合量は、水相の総質量に対して1.3質量%であった。界面活性剤の配合量は、水相の総質量に対して0.13質量%であった。
[Preparation of aqueous phase]
The aqueous phase was prepared in the same manner as in Example 1. 38 parts by weight of purified water was used to prepare the premix.
The amount of the carboxyvinyl polymer was 2.6% by mass based on the total mass of the premix, and the amount of the surfactant was 0.26% by mass based on the total mass of the premix.
The amount of the carboxyvinyl polymer was 1.3% by mass based on the total mass of the aqueous phase, and the amount of the surfactant was 0.13% by mass based on the total mass of the aqueous phase.

〔油相の調製〕
攪拌機を備えた予備配合槽へ、第1の有効成分、第2の有効成分、第1の基剤、第2の基剤、乳化剤、防腐剤、香料並びにアルカリ剤を投入し、各成分が溶解するまで、80~85℃下で攪拌を続けて油相を調製した。各成分の溶解は目視により確認した。
〔乳化〕
真空乳化装置の主配合槽中で攪拌している水相へ油相を添加し、乳化物が生成するまで攪拌を続けた。乳化物の生成は目視により確認した。
乳化物生成後、更に冷却(8~12℃)下で攪拌を行い、水中油型クリーム剤(pH5.0)を得た。
[Preparation of oil phase]
The first active ingredient, the second active ingredient, the first base, the second base, the emulsifier, the preservative, the flavoring, and the alkali agent were added to a preliminary blending tank equipped with a stirrer, and the mixture was stirred at 80 to 85°C until each ingredient was dissolved to prepare an oil phase. The dissolution of each ingredient was confirmed by visual inspection.
[Emulsification]
The oil phase was added to the aqueous phase under stirring in the main blending tank of the vacuum emulsifier, and stirring was continued until an emulsion was formed. The formation of an emulsion was confirmed by visual observation.
After the emulsion was produced, it was further stirred under cooling (8 to 12° C.) to obtain an oil-in-water cream (pH 5.0).

〔比較例〕
アルカリ剤を配合せずに調製した油相を水相へ添加して乳化行ってから15分後に該アルカリ剤のみを添加したことを除き、実施例2と同じ手順にしたがい水中油型クリーム剤(pH5.0)を得た。
Comparative Example
An oil-in-water cream (pH 5.0) was obtained according to the same procedure as in Example 2, except that an oil phase prepared without blending an alkaline agent was added to an aqueous phase, emulsified, and then the alkaline agent alone was added 15 minutes later.

〔粘度が均一な水中油型クリーム剤(乳化物)が生成するまで時間〕
実施例1~2及び比較例のそれぞれについて、アルカリ剤の投入から粘度が均一な乳化物(500kg)が生成するまでの時間を下記手順により測定した。まず、アルカリ剤の投入時(実施例1:第1の油相添加時。実施例2:油相添加時。比較例:アルカリ剤のみを添加した時)から5分毎に主配合槽の上部、中部及び下部の3カ所からサンプルを採取した。各サンプルの粘度を、BH粘度計(No.7ローター/20rpm/1min/20~30℃)にて測定した。3カ所から採取したサンプル間の粘度差が3Pa・s未満となったとき、粘度が均一な乳化物が生成したと判断した。測定結果を以下に示す。

Figure 0007576541000003
〇:3カ所から採取したサンプル間の粘度差が3Pa・s未満
×:3カ所から採取したサンプル間の粘度差が3Pa・s以上

乳化物形成後にカルボキシビニルポリマーの中和を行った比較例では、粘度が均一な水中油型クリーム剤が得られるまでに25分間を要した。一方、アルカリ剤を含む油相を水相に添加して乳化とカルボキシビニルポリマーの中和とを同時に行った実施例1及び2では、15分間で粘度が均一な水中油型クリーム剤が得られた。 [Time required for a uniformly viscous oil-in-water cream (emulsion) to form]
For each of Examples 1 and 2 and Comparative Example, the time from the addition of the alkaline agent to the formation of an emulsion (500 kg) with a uniform viscosity was measured by the following procedure. First, samples were taken from three locations, the upper, middle, and lower parts of the main blending tank, every 5 minutes from the time the alkaline agent was added (Example 1: when the first oil phase was added; Example 2: when the oil phase was added; Comparative Example: when only the alkaline agent was added). The viscosity of each sample was measured with a BH viscometer (No. 7 rotor/20 rpm/1 min/20-30°C). When the viscosity difference between the samples taken from the three locations was less than 3 Pa·s, it was determined that an emulsion with a uniform viscosity had been formed. The measurement results are shown below.

Figure 0007576541000003
◯: The viscosity difference between the samples taken from the three locations is less than 3 Pa·s. ×: The viscosity difference between the samples taken from the three locations is 3 Pa·s or more.

In the Comparative Example, where the carboxyvinyl polymer was neutralized after emulsion formation, it took 25 minutes to obtain an oil-in-water cream with a uniform viscosity, whereas in Examples 1 and 2, where the oil phase containing an alkaline agent was added to the aqueous phase to simultaneously perform emulsification and neutralization of the carboxyvinyl polymer, an oil-in-water cream with a uniform viscosity was obtained in 15 minutes.

本発明は、医薬品及び化粧品の製造分野で利用可能である。 The present invention can be used in the fields of pharmaceutical and cosmetic manufacturing.

Claims (6)

カルボキシビニルポリマーを含む水相へ、アルカリ剤、有効成分及び乳化剤を含む油相を添加して乳化を行う工程を含み、
更に、アルカリ剤、有効成分及び乳化剤を含む油相(第1の油相)を添加する前に、第2の有効成分を含む第2の油相を水相へ添加する工程を含むことを特徴とする、水中油型クリーム剤の製造方法。
The method includes a step of emulsifying the aqueous phase containing a carboxyvinyl polymer by adding an oil phase containing an alkaline agent, an active ingredient, and an emulsifier,
The method for producing an oil-in-water cream further comprises a step of adding a second oil phase containing a second active ingredient to the aqueous phase before adding the oil phase (first oil phase) containing an alkaline agent, an active ingredient and an emulsifier.
有効成分が、抗ヒスタミン剤、鎮痒剤、消炎鎮痛剤及び殺菌剤からなる群より選ばれる1種以上の物質である、請求項1に記載の製造方法。 The method according to claim 1, wherein the active ingredient is one or more substances selected from the group consisting of antihistamines, antipruritics, anti-inflammatory analgesics, and bactericides. 第2の有効成分が25℃で液体の物質であり、かつ、第1の油相に含まれる有効成分が25℃で固体の物質である、請求項に記載の製造方法。 2. The method according to claim 1 , wherein the second active ingredient is a substance that is liquid at 25°C, and the active ingredient contained in the first oil phase is a substance that is solid at 25°C. 第2の有効成分が、抗ヒスタミン剤、鎮痒剤、消炎鎮痛剤及び殺菌剤からなる群より選ばれる1種以上の物質である、請求項又はに記載の製造方法。 4. The method according to claim 1 , wherein the second active ingredient is one or more substances selected from the group consisting of antihistamines, antipruritics, anti-inflammatory analgesics and disinfectants. アルカリ剤がアミン類である、請求項1~のいずれか1項に記載の製造方法。 The method according to any one of claims 1 to 4 , wherein the alkaline agent is an amine. 乳化剤が非イオン性界面活性剤である、請求項1~5のいずれか1項に記載の製造方法。The method according to any one of claims 1 to 5, wherein the emulsifier is a non-ionic surfactant.
JP2021527789A 2019-06-28 2020-06-26 Method for producing oil-in-water cream Active JP7576541B2 (en)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
JP2019121245 2019-06-28
JP2019121245 2019-06-28
PCT/JP2020/025323 WO2020262641A1 (en) 2019-06-28 2020-06-26 Method for producing oil-in-water cream

Publications (2)

Publication Number Publication Date
JPWO2020262641A1 JPWO2020262641A1 (en) 2020-12-30
JP7576541B2 true JP7576541B2 (en) 2024-10-31

Family

ID=74060090

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2021527789A Active JP7576541B2 (en) 2019-06-28 2020-06-26 Method for producing oil-in-water cream

Country Status (4)

Country Link
JP (1) JP7576541B2 (en)
KR (1) KR102945578B1 (en)
CN (1) CN113811291A (en)
WO (1) WO2020262641A1 (en)

Citations (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP2006111542A (en) 2004-10-13 2006-04-27 Kanebo Cosmetics Inc Oil-in-water emulsified cosmetic
JP2014094933A (en) 2012-10-10 2014-05-22 Taisho Pharmaceutical Co Ltd External composition
WO2014168193A1 (en) 2013-04-11 2014-10-16 大正製薬株式会社 Composition for external use

Family Cites Families (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPH0735330B2 (en) * 1986-03-12 1995-04-19 久光製薬株式会社 Cream composition for external use
US5871760A (en) * 1994-11-28 1999-02-16 The Procter & Gamble Company Skin care compositions
EP1847243A1 (en) * 2005-01-17 2007-10-24 Taisho Pharmaceutical Co., Ltd O/w emulsion composition
JP5061521B2 (en) * 2005-08-29 2012-10-31 大正製薬株式会社 O / W type emulsion composition
AU2009310956B2 (en) * 2008-10-31 2015-07-16 Shiseido Company, Ltd. O/W emulsion composition
JP5829578B2 (en) 2012-06-13 2015-12-09 株式会社ヤクルト本社 Thickening composition containing acylated amino acids
EP3124049A4 (en) * 2014-03-27 2017-12-13 Pola Pharma Inc. Process for producing composition of emulsion preparation type
JPWO2015147296A1 (en) * 2014-03-27 2017-04-13 株式会社ポーラファルマ Method for producing emulsifier-type composition
JP2015193626A (en) * 2014-03-28 2015-11-05 株式会社ポーラファルマ Oil-in-water emulsion pharmaceutical composition and production method thereof

Patent Citations (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP2006111542A (en) 2004-10-13 2006-04-27 Kanebo Cosmetics Inc Oil-in-water emulsified cosmetic
JP2014094933A (en) 2012-10-10 2014-05-22 Taisho Pharmaceutical Co Ltd External composition
WO2014168193A1 (en) 2013-04-11 2014-10-16 大正製薬株式会社 Composition for external use

Also Published As

Publication number Publication date
KR102945578B1 (en) 2026-03-30
JPWO2020262641A1 (en) 2020-12-30
CN113811291A (en) 2021-12-17
KR20220027052A (en) 2022-03-07
WO2020262641A1 (en) 2020-12-30

Similar Documents

Publication Publication Date Title
CN102573762B (en) The preparation method of high viscosity O/W cream
TW219952B (en)
JP2017222594A (en) Oil-in-water emulsified external preparation composition
CN108159414B (en) Water-in-oil adjuvant for animal vaccine and preparation method and use thereof
JPH02174927A (en) O/w type multiphase emulsion and preparation thereof
CN1832723A (en) Perfume oil emulsions
JP4318332B2 (en) Method for producing emulsified liquid composition
JP7576541B2 (en) Method for producing oil-in-water cream
JP3952108B2 (en) Method for producing O / W emulsion
TWI614334B (en) Viscous detergent composition
CN1325625C (en) Stable emulsions
JP5191026B2 (en) Cleaning composition
JPH0344322A (en) Microemulsion formulation and production thereof
JP6392484B1 (en) Creamy external composition and method for producing the same
JP5100158B2 (en) Vesicle aqueous dispersion and method for producing the same
JPH10298149A (en) Dispersion of quaternary ammonium salt at high concentration and its preparation
WO2012098877A1 (en) Process for producing vesicle composition
JP2005307069A (en) Method for producing liquid composition and method for filling the same
JP5551818B1 (en) Method for producing miconazole nitrate-containing solution formulation
JP5732118B2 (en) Vesicle composition
JP5873732B2 (en) Method for producing vesicle composition
JP2000355519A (en) Manufacturing method of emulsified cosmetic
JP4456778B2 (en) Gel composition and external preparation for skin comprising the same
JP2002282677A (en) Oil-in-water type emulsion composition and method for producing the same
JP6246660B2 (en) Method for producing miconazole nitrate-containing solution formulation

Legal Events

Date Code Title Description
A621 Written request for application examination

Free format text: JAPANESE INTERMEDIATE CODE: A621

Effective date: 20230626

A131 Notification of reasons for refusal

Free format text: JAPANESE INTERMEDIATE CODE: A131

Effective date: 20240430

A521 Request for written amendment filed

Free format text: JAPANESE INTERMEDIATE CODE: A523

Effective date: 20240621

TRDD Decision of grant or rejection written
A01 Written decision to grant a patent or to grant a registration (utility model)

Free format text: JAPANESE INTERMEDIATE CODE: A01

Effective date: 20240919

A61 First payment of annual fees (during grant procedure)

Free format text: JAPANESE INTERMEDIATE CODE: A61

Effective date: 20241021

R150 Certificate of patent or registration of utility model

Ref document number: 7576541

Country of ref document: JP

Free format text: JAPANESE INTERMEDIATE CODE: R150